In 2022, Exzell Pharma became part of the Biolab Farmaceutica Group, marking a significant step in our mission to provide high-quality healthcare solutions to Canadians and beyond. This acquisition strengthens Exzell with Biolab’s expertise, advanced resources, and international reach, allowing us to expand our offerings in natural health products, OTC solutions, and expand in the future, adding prescription medications. With Biolab’s support, we continue to enhance our production capabilities, ensure the highest compliance standards, and foster innovation across all product lines.
“Exzell by Biolab” combines Biolab’s global expertise with Exzell’s trusted presence in the Canadian market, positioning us as a leader in both human and animal health. Together, we are committed to improving healthcare accessibility and delivering solutions that prioritize the well-being of communities across Canada.